information came out on March 9, but NOT a recall. In some cases this information related to these drugs being used in a manner that was inconsistant with the manufacturers recomendations. The FDA says:
"At this time, ESAs appear to be safe and effective when used according to the recently revised product labeling, at the recommended dose and approved indication. The revised labeling reflects the current knowledge regarding risks and benefits that patients and their physicians should consider. The FDA continues to assess data as it becomes available. "